| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Ernest Mario last filed a Form 4 in June 2024, as Director at HYPD. The filings on record cover 3 companies. From June 2015 to June 2024, the filings on record show 16 open-market purchases and 2 sales. Ernest Mario's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 382,706 shares of HYPD. Net of sales, the HYPD filings show accumulation of 208,402 shares.
Shares as reported in the last Form 4 for each company; the most recent is from June 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2016 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 25,000 | $0.99 | $24,750.00 | +1.4% | |
| Jun 8, 2016 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 50,000 | $1.24 | $62,000.00 | +2.7% | |
| May 20, 2016 | SLNO Soleno Therapeutics Inc | Director | Buy | 48,806 | $1.18 | $57,639.07 | +2.7% | |
| Nov 18, 2015 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 50,000 | $1.77 | $88,500.00 | +3.1% | |
| Sep 14, 2015 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 15,000 | $2.28 | $34,200.00 | +1.0% | |
| Aug 21, 2015 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 16,228 | $1.91 | $30,995.48 | +1.1% | |
| Aug 12, 2015 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 10,000 | $1.64 | $16,440.00 | +0.8% | |
| Aug 11, 2015 | SLNO Soleno Therapeutics Inc | Director, 10% Owner | Buy | 50,000 | $1.77 | $88,500.00 | +3.9% |